BMO Capital Upgrades Halozyme Therapeutics (HALO) to Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. BILL
4. MRK
5. MRNA
6. LOW
7. ADI
8. COTY
9. RARE
10. TJX

Go back to BMO Capital Upgrades Halozyme Therapeutics (HALO) to Outperform
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 107.62 --0 (-0%)
Previous Close $107.62    52 Week High $18.39 
Open $107.62    52 Week Low $6.96 
Day High $107.62    P/E N/A 
Day Low $107.62    EPS $-0.58 
Volume 4,465